Urology Flashcards
Viral pleuritis
Viral pleuritis is a viral infection of the pleurae.
Viral pleuritis is most commonly caused by infection with coxsackie B virus. Occasionally, echovirus causes a rare condition known as epidemic pleurodynia (Bornholm pleurodynia), manifesting as pleuritis, fever, and chest muscle spasms. The condition occurs in the late summer and affects adolescents and young adults.
The primary symptom of viral pleuritis is pleuritic pain; pleural friction rub may be a sign.
Diagnosis is suspected in patients with pleuritic chest pain with or without systemic symptoms of viral infection. Chest x-ray is usually done. Other causes of pleuritic chest pain, such as pulmonary emboli and pneumonia, need to be considered and sometimes ruled out with testing.
Treatment is symptomatic with oral nonsteroidal anti-inflammatory drugs (NSAIDs) or a short course of oral opioids if needed.
Pulmonary embolism
Pulmonary embolism (PE) is a blockage of an artery in the lungs by a substance that has moved from elsewhere in the body through the bloodstream (embolism). Symptoms of a PE may include shortness of breath, chest pain particularly upon breathing in, and coughing up blood. Symptoms of a blood clot in the leg may also be present, such as a red, warm, swollen, and painful leg. Signs of a PE include low blood oxygen levels, rapid breathing, rapid heart rate, and sometimes a mild fever. Severe cases can lead to passing out, abnormally low blood pressure, obstructive shock, and sudden death.
PE usually results from a blood clot in the leg that travels to the lung. The risk of blood clots is increased by cancer, prolonged bed rest, smoking, stroke, certain genetic conditions, oestrogen-based medication, pregnancy, obesity, and after some types of surgery. A small proportion of cases are due to the embolization of air, fat, or amniotic fluid. Diagnosis is based on signs and symptoms in combination with test results. If the risk is low, a blood test known as a D-dimer may rule out the condition. Otherwise, a CT pulmonary angiography, lung ventilation/perfusion scan, or ultrasound of the legs may confirm the diagnosis. Together, deep vein thrombosis and PE are known as venous thromboembolism (VTE).
Pulmonary embolism treatment
Pharmacological treatment options for confirmed pulmonary embolism (PE) include:
Low molecular weight heparin (LMWH).
Fondaparinux.
Unfractionated heparin.
Oral anticoagulant treatment (warfarin, apixaban, or rivaroxaban).
LMWH followed by an oral anticoagulant (dabigatran or edoxaban).
Mechanical (or physical) interventions may be considered in some cases.
Inferior vena cava (IVC) filters are designed to trap fragmented thromboemboli from the deep leg veins en route to the pulmonary circulation (whilst preserving blood flow in the IVC filter).
Various filters are available and can be placed in the IVC filter on either a temporary basis (for example in people with PE who cannot have anticoagulation treatment) or a permanent basis (for example in people with recurrent PE despite adequate anticoagulation treatment after alternative treatments have been considered).
Thrombolytic therapy may be used to remove the embolic material from the pulmonary arteries by promoting lysis of blood clots.
The thrombolytic agent can either be given into a peripheral vein (systemic thrombolysis) or directly into the pulmonary arteries via a catheter (catheter-directed thrombolysis). It can also be combined with attempts to break up the thrombus by using mechanical devices inserted via a catheter into the major pulmonary arteries or attempting to aspirate the clot (pharmacomechanical thrombolysis).
Pharmacological thrombolytics that have been used in the treatment of PE include streptokinase, urokinase, and rt-PA. These plasminogen activators stimulate the fibrinolytic system, leading to the lysis of blood clots. However, their mechanisms of action differ slightly: rt-PA is a fibrin-specific agent, preferentially activating plasminogen on the clot surface, whilst streptokinase and urokinase are non-selective agents.
Open pulmonary embolectomy (surgical removal of clots in the pulmonary arteries) is an alternative used less commonly in modern practice.
Benign prostatic hyperplasia
40% of men in their 50s. More common in afroamericans + high testosterone. Shows urinary frequency, urgency, hesitancy, poor stream, post-micturition dribble, incomplete voiding -> strain -> syncope.
PSA cut-offs: 40-49 = 2.5mcg/L, 50-59= 3.5, 60-69 = 4.5, 70-79= 6.5.
What needs immediate referral- AKI, acute retention, inc PSA, In two weeks for haematuria, dysuria wi/o bacteria, night time incontinence.
Treating BPH
Tamsulosin and other alpha blockers like doxazocin, terazosin. Tamsulosin has inc risk of intraoperative floppy iris syndrome.
Can also consider 5-alpha reductase inhibitors- blocks testosterone eg finasteride. Takes some months to work but helps retention- give if LUTs, 30g+, or PSA= 1.4ng/ml. Can combine with alphas if not responding to alphas alone. But alpha blockers are contraindicated with postural hypotension and micturition syncope. Surgery includes prostatectomy or TURP.
Prostate cancer
Signs of locally invasive prostate cancer- haematuria, LUTs, haematospermia, perineal +suprapubic pain, tenesmus, lethargy, weight loss.
DRE might show hard, irregular prostate gland, nodular, induration, adhesion to surrounding tissue. Palpable seminal vesicles.
Treatment for prostate cancer
Offer PSA= DRE to anyone with LUTs, erectile dysfunction, visible haematuria. Options are radical prostatectomy , external beam radiotherapy.
Brachytherapy- ADT/ androgen deprivation eg LHRH goserelin, triptorelin.
Or anti androgens cyproterone acetate (steroid) or bicalutamide (not).
If cancer is hormone sensitive, give apalutamide+ ADT if docetaxel chemo x suitable or relapsing with risk of metastasis- eg PSA doubles. 2nd line= prednisone + cabazitaxel or prednisolone.
Enzalutamide is given before chemo, after failed ADT+metastasises.
Prostatis
Ciprofloxacin is 1st choice treatment. 2nd line is levofloxacin or cotrimoxazole. If prostatis is chronic = trimethoprim or doxycycline. If abacterial, give NSAIDs.
Bladder cancer
90% of bladder cancers are transitional cell carcinomas, rest are squamous mostly. 1/2 of bladder cancers are caused by smoking. Hardware manufacturing also impacts. Cyclophosphamide is also a risk. Squamous cell is more likely following chronic inflammation from renal stones or catheters. Main symptoms - gas haematuria, painless. Adenocarcinoma can come from embryological remnants.
Referral guideline- +45, visible haematuria wi/o infection or reoccurs after successful UTI treatment. Over 60 w/ microhaematuria and dysuria or raised white cells.
Bladder cancer treatments
TURBT alone if in the superficial muscle with intravesical mitomycin C. If high risk, give immunotherapy w/ BCG or cystectomy. If invasive- cisplatin chemo+ radical cystectomy. If lymph nodes, follow up with neoadjuvant cisplatin. If metastatic, give cisplatin combo or carboplatin and gemcitabine.
Renal cancer
80% renal cell carcinoma. Most common in 60s. Risk factors- classic lifestyle, long term dialysis, tuberous sclerosis, renal transplant recipients.
Presentations= asymptomatic or fatigue, weight loss, macroscopic haematuria, varicocele, oedema, HTN.
25% show metastasis- haemoptysis, bone pain or fracture. Paraneoplastic symptoms= neuromyopathy, anaemia, polycythaemia, amyloidosis, hypercalcaemia.
Can also locally invade adrenals, liver, spleen, colon, pancreas, renal vein -> vena cava.
Renal cancer treatments
1st line is partial nephrectomy if under 7cm. Can do a complete + IFN-alpha or IL-2 or sunitinib.
Schistosomiasis
Tropical flatworm that causes abdominal pain, diarrhoea, bloody stool, haematuria, urinary retention, cercarial dermatitis that looks like scabies. From freshwater snails and also prawns. It’s common in children who swim in their waters or those who ingest them. Commonly treated with praziquantel.
Acute reaction = katayama fever, 2-8 wekks after infection. Affects lungs and liver. Usually self-resolves but can be given prednisone and praziquantel.
Pseudohaematuria causes
Rifampicin, methyldopa, hyperbilirubinuria, myoglobulinuria, beetroot and rhubarb.
Treating urinary retention
Acute = catheterise, give 2+ days doxazosin or another alpha blocker, then remove.
Chronic- intermittent catheter offered before indwelling +/- alpha blocker is still symptomatic. Also the options of surgery.